PEDIATRIC ATOPIC DERMATITIS | M16-813 | PHASE II
Status:
Drug:
Timeline:
Detailed Description
Eligibility
Exclusions
If you’re interested in participating, please SEND US AN EMAIL AND/OR CONTACT US and our research team will be in touch.
Status:
Drug:
Timeline:
If you’re interested in participating, please SEND US AN EMAIL AND/OR CONTACT US and our research team will be in touch.
AvantDerm Research is where we advance the field of dermatology and develop new treatments and products. We are at the leading edge of science and committed to improving skin health for everyone.